ID   HyCyte RBE stable cell line for hPSMB9 overexpression
AC   CVCL_F4RJ
SY   RBE stable cell line for hPSMB9 overexpression
DR   Hysigen; CGSC-M32591
CC   Population: Japanese.
CC   Characteristics: Transfected with pLV[Exp]-CMV>hPSMB9[NM_002800.5]-EF1A>copGFP:T2A:Hygro-WPRE.
CC   Doubling time: 48-60 hours (Hysigen=CGSC-M32591).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; EGFP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9546; PSMB9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4896 ! RBE
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//